calendar
8,982 catalysts · 3,126 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 583 earnings
8,982 catalysts · 3,126 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 583 earnings
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing
methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 — Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. — Status: Ongoing
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 — Reason: Failed Disintegration Specifications: above the time expected. — Status: Ongoing
Product code: QHE. Advisory committee: Orthopedic. Type: Special
Product code: MAX. Advisory committee: Orthopedic. Type: Traditional
Product code: PNO. Advisory committee: Cardiovascular. Type: Special
Product code: LPH. Advisory committee: Orthopedic. Type: Traditional
Product code: FYA. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: OVE. Advisory committee: Orthopedic. Type: Special
Supplement type: 30-Day Notice. Product code: QVG. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: FTR. Advisory committee: SU. Decision: OK30
Supplement type: 30-Day Notice. Product code: FTR. Advisory committee: SU. Decision: OK30
Supplement type: 30-Day Notice. Product code: FWM. Advisory committee: SU. Decision: OK30
Supplement type: 30-Day Notice. Product code: PHP. Advisory committee: MG. Decision: OK30
Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30
Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 Product Description: The STA¿ - Liatest¿ Free Protein S kits are intended for use on STA-R¿ and STA Compact¿ for the quantitative antigenic assay of free protein S in human citrated plasma by the immuno-turbidimetric method. Component: Not Applicable — Reason: The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values. — Status: Ongoing
AI grant. $439,250. PI: Matthew Daugherty
AI grant. $610,124. PI: Soman N Abraham
HD grant. $35,832. PI: Pond Ezra
DC grant. $779,636. PI: Brian Lin
DK grant. $765,558. PI: Shengmin Sang
AI grant. $437,250. PI: Ryan K Shields
AI grant. $670,017. PI: Paula Maria Oliver
AI grant. $436,605. PI: Charles Kyriakos Vorkas
AI grant. $443,850. PI: Kathryn A Knoop
AI grant. $553,779. PI: Nathaniel J Moorman
AI grant. $200,000. PI: CURT M HORVATH
AI grant. $560,455. PI: Lars Dietrich
AI grant. $2,800,280. PI: Mandy J McGeachy
DE grant. $340,149. PI: Gina Lewin
DK grant. $123,750. PI: Jacqueline Anne Seiglie
DK grant. $791,520. PI: Matthew A Burchill
AI grant. $791,990. PI: PATRICK L SINN
AI grant. $462,000. PI: Miguel Fribourg
AI grant. $791,797. PI: Carla Rose Nowosad
AI grant. $427,625. PI: Takeshi Egawa
NS grant. $37,249. PI: Haley Jetter
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION
Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION
Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION
Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL
Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL
Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION